A bioengineered anti‐VEGF protein with high affinity and high concentration for intravitreal treatment of wet age‐related macular degeneration

• Main Authors: Chengnan Huang (Author), Yuelin Wang (Author), Jinliang Huang (Author), Huiqin Liu (Author), Zhidong Chen (Author), Yang Jiang (Author), Youxin Chen (Author), Feng Qian (Author)
• Format: Book
• Published: Wiley, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Intravitreal (IVT) injection of anti‐vascular endothelial growth factor (anti‐VEGF) has greatly improved the treatment of many retinal disorders, including wet age‐related macular degeneration (wAMD), which is the third leading cause of blindness. However, frequent injections can be difficu...